Sort   by:  
 Page size 
UnknownCellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines.
Not available
S-EPMC7469576 | biostudies-literature
UnknownAnalysis of SIVmac Envelope-Specific Antibodies Selected Through Phage Display.
Not available
S-EPMC5749048 | biostudies-literature
ProteomicsHLA class II ligandome of C1R BLCL cell line
HLA-DR, -DQ and -DP ligands from transfected C1R cells were isolated using LB3.1, SPVL3 and B721 antibodies respectively.
ORGANISM(S): Homo sapiens (Human) 
2021-08-18 | PXD025877 | Pride
Class ii C1r Dp Immunopeptidomics Dq Hla-dr 
UnknownHuman B cells and dendritic cells are susceptible and permissive to enterovirus D68 infection.
Not available
S-EPMC10900886 | biostudies-literature
ProteomicsHLA-DQ8 Immunopeptidomics, Type 1 Diabetes
In this project we will investigate the peptides present by HLA-DQ8. We will identify linear, spliced and PTM peptides from one cell line.
ORGANISM(S): Homo sapiens (Human) 
2021-07-07 | PXD019466 | Pride
Immunopeptidomics Type 1 diabetes Spliced 
UnknownComprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.
Not available
S-EPMC4574158 | biostudies-literature
ProteomicsClass II Immunopeptidome of 9033 cells
Cells were treated with either PBS (mock) or hydroxychloroquine (HCQ).
ORGANISM(S): Homo sapiens (Human) 
2022-02-17 | PXD029648 | Pride
Immunopeptidomics Hcq 9033 Class ii Hla 
UnknownHLA-DPB1 genotype variants predict DP molecule cell surface expression and DP donor specific antibody binding capacity.
Not available
S-EPMC10808447 | biostudies-literature
ProteomicsHLA-DR ligands from BLCLs 9022 and 9087
HLA-DR-bound peptides eluted from B-lymphoblastoid cell lines 9022 and 9087.
ORGANISM(S): Homo sapiens (Human) 
2020-03-11 | PXD017682 | Pride
Human Blcl Immunopeptidome Hla class ii Hla-dr 
ProteomicsExtending the Comprehensiveness of Immunopeptidome Analyses Using Isobaric Peptide Labeling
Defining the repertoire of peptides presented by the major histocompatibility complex class I (MHC I) is a key step towards the identification of relevant antigens for cancer immunotherapy. However, the identification of the cancer-specific antigens is a significant analytical challenge in view of t...
ORGANISM(S): Homo sapiens (Human) 
2020-11-16 | PXD017918 | Pride
Tmt Minor antigens Mhc Tumor specific antigens Faims 
Sort   by:  
 Page size